Skip to content
10-K/A

Annual Report

Artiva Biotherapeutics, Inc. ARTV

0001193125-26-197115

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 24.72M sh